Vivos Therapeutics, Inc. recently filed a Form 4 with the Securities and Exchange Commission, indicating significant insider activity within the company. Form 4 is a document required to be filed with the SEC whenever there is a material change in the holdings of company insiders. This could include the buying or selling of company stock by executives, directors, or beneficial owners. Investors often monitor these filings closely as they can provide insights into the confidence and sentiment of insiders within the company.
Vivos Therapeutics, Inc. is a company focused on providing innovative solutions for various health issues, particularly in the field of sleep disorders and breathing difficulties. Their products aim to offer non-invasive and effective treatments for conditions such as sleep apnea. For more information about Vivos Therapeutics, Inc., you can visit their official website here.
Overall, this Form 4 filing by Vivos Therapeutics, Inc. sheds light on recent insider activity within the company. Investors and analysts may interpret these transactions as a signal of confidence in the company’s future prospects.
Read More:
Vivos Therapeutics, Inc. SEC Filing (Form 4) Reveals Key Updates from Issuer
Leave a Reply